Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Tigers Rumors

Tigers To Select Ryan Kreidler, Recall Spencer Torkelson

By | at

The Tigers are planning to select infield prospect Ryan Kreidler onto the major league roster tomorrow, relays Chris McCosky of the Detroit News (Twitter link). First baseman Spencer Torkelson will also be recalled from Triple-A Toledo, seemingly filling the two vacant active roster spots associated with the September expansion from 26 to 28 players. Detroit technically needs to create a 40-man roster vacancy for Kreidler, but they can do so by transferring Austin Meadows to the 60-day injured list without affecting his eligibility timeline.

Kreidler is one of the better prospects in the Detroit organization. A fourth-round pick from UCLA in 2019, the 6’4″ infielder spent his draft year in short season ball. After the canceled 2020 minor league campaign, he was bumped to Double-A Erie in 2021. Kreidler performed well over 88 games there before mashing following a late-season bump to Triple-A Toledo. He entered 2022 among the top 11 farmhands in the system according to each of Baseball America, FanGraphs and Keith Law of the Athletic.

After the impressive late-season run in the upper minors, Kreidler looked like a candidate to factor into the MLB mix early this year. He broke his right hand in April, though, an injury that cost him six weeks of action. By the time he was healthy again in early June, the Tigers had fallen well out of the potential playoff mix, and they elected to give Kreidler a longer run in Toledo. He’s played in 55 games there this year, hitting .218/.359/.421 with a robust 14.7% walk rate but a worrisome 29% strikeout percentage.

During their midseason re-rank of the Detroit system, BA slotted Kreidler eighth. The outlet raises concerns about his propensity for whiffs but praises his defense all around the infield and solid power upside. The 24-year-old has played primarily shortstop in the minors, although he seems likelier to factor in at second or third base down the stretch with Javier Báez entrenched at short. Jeimer Candelario has underwhelmed at the hot corner all season, while the Tigers have turned to utilityman Willi Castro at the keystone with Jonathan Schoop on the injured list.

Kreidler would’ve needed to occupy a 40-man roster spot this offseason if the Tigers didn’t want to make him available in the Rule 5 draft. They’ll take advantage of the expanded active rosters to get a look at him a few weeks earlier than necessary. With the club’s attention squarely turned to 2023 at this point, there’s an opportunity for Kreidler to try to get off on a strong foot as he looks to carve out a spot next season.

Torkelson is already on the 40-man roster, of course. He broke camp as the team’s primary first baseman. The former first overall pick and consensus top prospect had hit very well in the minor leagues, and the club justifiably felt he could carry that over against MLB pitching. That hasn’t happened yet, as Torkelson owns a .197/.282/.295 line with only five home runs through 298 plate appearances.

After three months of struggles, the Tigers optioned the 23-year-old back to Toledo in mid-July. He’s hit .228/.347/.394 with five longballs in 34 games since then. That’s obviously far better than his first crack against major league arms, but it’s still well shy of the .238/.350/.531 mark he posted there late last season — particularly from a power perspective.

Torkelson is still a key piece of the future in Detroit, even if his initial MLB look was underwhelming. Manager A.J. Hinch seems likely to pencil him back in as the everyday first baseman for the final five weeks, with Torkelson trying to establish himself as the favorite for that job coming out of camp next year. He spent enough time on his optional stint that he won’t accrue a full year of MLB service this season, so Torkelson will be under club control through at least 2028.

Previewing Upcoming Opt-Out Decisions And Player Options

By | at

With the offseason approaching, so is the time for players and teams to decide upon any 2023 options in their contracts. MLBTR has taken a look through various option decisions in recent weeks: first with players whose deals contain vesting provisions, then a respective look at the team options in both the American and National Leagues.

Today, we’ll turn our attention to the players’ side. A number of players could hit free agency this winter either by triggering an opt-out clause in their current deal or bypassing a player option for the 2023 campaign. We’ll take a run through those decisions, many of which will have implications at the very top of the free agent market.

Note: All stats referenced are through play Sunday

Elite Potential Free Agents

  • Nolan Arenado, Cardinals 3B (can opt out of final five years and $144MM)

Arenado was already on a Hall of Fame trajectory before 2022, but he’s bolstering his case with the best season of his career. Through 500 plate appearances, he owns a .306/.370/.567 line with 27 home runs. He’s had seasons with that kind of slash line in years past, but they came with the caveat that he’d played half his games at Coors Field. That’s no longer a factor, and it’s easily his best offensive output once one adjusts for the ballpark. Arenado’s 162 wRC+ is the fourth-best mark among qualified hitters.

That kind of offensive production alone would get him in the MVP discussion, but Arenado’s obviously valuable for far more than his bat. One of the best defensive third basemen in MLB history, he’s continued to post elite marks with the glove even as he’s entered his 30s. Arenado is among the top handful of players in the game. While walking away from $144MM wouldn’t be an easy decision, it’d seem the prudent one from a strict financial perspective. Freddie Freeman received six years and $162MM from the Dodgers (albeit with deferrals that reduced the net present value closer to the $148MM range) headed into his age-32 season. Freeman was coming off a 135 wRC+ platform showing, and he plays a less valuable position. Arenado and his camp could make a strong argument the Freeman contract should represent his floor, and it’s not outlandish to seek a six-year deal at the $35MM annual range Anthony Rendon received from the Angels (which would bring the guarantee to $210MM).

On paper, Arenado’s opt-out decision looks like a slam dunk. There’s at least some amount of uncertainty, though, as he forewent an opt-out opportunity last offseason and told Derrick Goold of the Post-Dispatch it was “always the plan” to remain in St. Louis long term. Passing on free agency coming off a .255/.312/.494 showing in 2021 is a lot easier than doing so after a career-best year that should make him an MVP finalist. Maybe he’s comfortable enough with the Cardinals he’ll return, but he’d probably be leaving a lot of money on the table to do so. At the very least, he looks to have a case for a renegotiation of his contract with the Cards, which is slated to pay him just $15MM in the final season (2027).

  • Carlos Correa, Twins SS (can opt out of final two years and $70.2MM this offseason; deal also contains post-2023 opt-out if Correa opts in this winter)

Regarded by many (MLBTR included) as the top free agent in last winter’s class, Correa reportedly turned down at least one ten-year offer early in the offseason in search of a guarantee that rivaled the $341MM Francisco Lindor had received from the Mets last April. That proposal seemingly never came, and Correa reversed course in Spring Training. He signed a shocking three-year deal with the Twins that guaranteed him the largest annual salary ($35.1MM) for a free agent position player and afforded the opportunity to retest the market in either of the next two offseasons via opt-out.

Conventional wisdom was that Correa was sure to trigger his first opt-out and make another run at a long-term deal in a winter unaffected by a lockout. That still seems likely, although he hasn’t resoundingly made the case for teams to be more willing to approach the Lindor range that they had been. He’s having a similar offensive season as he did during his final year with the Astros. After posting a .279/.366/.485 showing his last year in Houston, Correa is hitting .276/.355/.439 over 440 plate appearances with Minnesota. His raw power production is down, but that’s not quite as alarming when considering the leaguewide slugging percentage has dropped from .411 to .395. Perhaps of greater concern is that the elite defensive marks that garnered Correa a Gold Glove last season are unanimously down, ranging anywhere from below-average (-2 Outs Above Average) to solid (+4 Defensive Runs Saved, +1 Ultimate Zone Rating).

There’s no question Correa’s an excellent player having a very good season. Yet he’s not likely to wind up a top five finisher in MVP balloting as he did in 2021. He’d top a $200MM guarantee on the open market, but he’s unlikely to reach the kind of money he anticipated last offseason. Could he return to Minnesota (where he’s by all accounts very happy) for one more year and look to trigger his post-2023 opt-out after hopefully putting up MVP-caliber numbers? That feels unlikely, but he’s already bet on himself once and would only be entering his age-29 season if he put off opting out for a year.

Bogaerts has been the Red Sox’s everyday shortstop since 2014, but his time in Boston could be nearing its end. He and the club didn’t make progress in extension talks this spring, and he’s a lock to opt out and top $60MM on the open market barring a catastrophic injury. One of the game’s top offensive shortstops, Bogaerts is amidst another strong season. He carries a .303/.372/.448 line through 508 plate appearances. His slugging output is below where it was from 2018-21, but he consistently gets on base and has a strong pre-2022 track record from a power perspective.

One can quibble about certain aspects of Boagerts’ profile. In addition to this year’s slugging dip, he’s traditionally rated as a below-average defender. Even with generally solid defensive metrics this season, clubs will probably have some question whether he’ll eventually need to move to second or third base. Those are nitpicks for whether Bogaerts would be a worthwhile investment in the $180MM – $200MM range, though. A 30-year-old shortstop with an elite durability track record and a .299/.370/.478 line since the start of 2020, he’s certainly going to shatter $60MM even if the market takes a relatively pessimistic view of his long-term projection.

  • Jacob deGrom, Mets RHP (can opt of final year and $33.5MM this offseason)

There’s no suspense with this one, as deGrom has publicly maintained his plan to opt out for months. That’s in spite of elbow/shoulder injuries that kept him from throwing a major league pitch between July 2021 and this August. With only one guaranteed year remaining on his deal (plus a 2024 club option that’d go into effect if he doesn’t opt out this winter), that’s been a pretty easy call. To the extent there may have been any lingering doubts, deGrom has silenced them with his first five starts since returning from the injured list. He’s looked like his vintage self, averaging 99.3 MPH on his fastball while posting a laughable 46:2 strikeout-to-walk ratio through 29 1/3 innings. On an inning-for-inning basis, he’s the best starting pitcher on the planet.

deGrom’s free agent case will be fascinating. Even if he finishes the season healthy, he’ll have gone three consecutive years without topping 15 starts or 100 innings (although he’s obviously not at fault for the shortened 2020 schedule). What kind of volume a signing team can expect is an open question, particularly as he enters his age-35 season. Yet the upside of a healthy deGrom is through the roof. He’ll receive a multi-year deal that beats the $33.5MM remaining on his current contract. Can he top teammate Max Scherzer’s $43.333MM AAV over a three or even four-year term? Time will tell.

While we’re on the topic of upper-echelon starting pitchers who are basically certain to opt out, let’s turn to Verlander. The future Hall of Famer triggered a $25MM option for next season by throwing 130 innings, but that’s largely a moot point. Verlander told Ken Rosenthal of the Athletic last week he was likely to opt out if things went as planned down the stretch. It’d have been surprising if he were even considering exercising the option.

Verlander has returned from 2020 Tommy John surgery to lead the major leagues with a 1.84 ERA. He’s striking out 26.5% of opponents and has a strong argument for a third career Cy Young award. He’s also a proven playoff performer and a prototypical ace who eats about as many innings as anyone else in the game. Even heading into his age-40 season, Verlander can try to beat the Scherzer AAV on a multi-year contract.

Verlander did injure his calf in his most recent start, resulting in a placement on the injured list just this afternoon. The Astros announced that an MRI of his calf revealed “fascial disruption, but no muscle fiber disruption” — an extremely specific diagnosis but one that both Verlander and GM James Click touted as good news. Click expressed hope the injury will be short-term, and Verlander suggested that had he sustained damage to the muscle fibers themselves, he’d likely have missed the remainder of the regular season and perhaps part of the postseason.

The manner to which Verlander rebounds will obviously be key in his opt-out scenario, but if he misses only a couple weeks’ time and returns strong for his final regular-season and postseason starts, this opt-out is an easy call.

We’ll wrap up the trifecta with Rodón, who’s also going to have an easy decision, barring injury. While there was some trepidation about Rodón’s breakout 2021 season — both due to his inconsistent track record before last season and some shoulder soreness and a velocity drop last August — he’s doubled down and looks to have cemented himself among the game’s top ten starters. Rodón has avoided the injured list thus far, and he’s striking out 32.1% of opponents while posting a 2.81 ERA through 25 starts. By topping 110 innings, he earned the right to opt out after this season.

Heading into his age-30 campaign, he should land the nine-figure deal that eluded him last offseason. Between his youth and last two years of production, Rodón has an argument for the largest guarantee of any free agent starter. He won’t get paid at the deGrom or Verlander level on an annual basis, but he could push for six years and look to top $150MM.

Quality Regulars Likely To Opt Out

Rizzo’s market last offseason seemed a bit underwhelming. The veteran first baseman was coming off two fine but unspectacular seasons, and it looked as if his best days might be behind him with his mid-30s approaching. Rizzo still made plenty of contact and hit the ball hard, but he’d gotten quite pull-oriented and had rough ball-in-play results against an increasing number of defensive shifts. He signed a two-year deal with the Yankees that paid him matching $16MM salaries and allowed him to opt out after this season.

That now looks like an easy call, as Rizzo has bounced back with a year more reminiscent of his peak days with the Cubs. He carries a .223/.337/.480 line and is going to top 30 homers for the first time since 2017. He’s still getting dismal results on balls in play and doesn’t have a particularly impressive batting average, but even that looks as if might turn around next year. It’s widely expected MLB will institute limits on shifting next spring. Few players would stand to benefit more than Rizzo, who’s facing a shift on a whopping 83.5% of his plate appearances according to Statcast. His age and lack of defensive versatility will limit the length of any deal, but he’ll probably beat the $16MM salary over at least a two-year term, even if the Yankees tag him with a qualifying offer.

The Padres’ signing Profar to a three-year, $21MM deal that allowed him multiple opt-out chances was one of the more eyebrow-raising moves of the 2020-21 offseason. The switch-hitter was coming off a solid 2020 campaign, but that shortened schedule was the first in which he’d posted above-average production. It looked like a misstep when he struggled last year and unsurprisingly forewent his first opt-out clause, but Profar has rewarded the organization’s faith with a career-best showing in 2022.

Through 530 plate appearances, he’s hitting .241/.339/.387 with 12 homers. He’s walking at a robust 12.3% clip while only going down on strikes 15.1% of the time. He looks like a solid regular, and headed into his age-30 season, Profar’s a candidate for another multi-year deal this time around. After major throwing issues as an infielder early in his career, he’s played exclusively left field this year. Profar isn’t a prototypical corner outfield masher, but his plate discipline and bat-to-ball skills should allow him to top the guaranteed money remaining on his current deal.

Starting Pitchers With High Buyouts

Walker signed a $20MM guarantee with the Mets over the 2020-21 offseason. The deal was front-loaded but came with a $6MM player option or a $3MM buyout for 2023. Adding a player option allowed the Mets to soften the contract’s luxury tax hit. Because player options are treated as guaranteed money, it technically qualified as a three-year, $20MM deal with a $6.67MM average annual value for CBT purposes. Yet the $3MM gap between the option value and the buyout meant Walker was a virtual lock to opt out, barring injury that made him unable to pitch next season. The Associated Press reports the option has various escalators that could push its value as high as $8.5MM if Walker throws 175 innings this year, but even that figure is modest enough he’s going to decline.

Walker should opt out in search of a multi-year deal, as he’s been a valuable mid-rotation arm for New York. Over 117 1/3 frames, he owns a 3.38 ERA despite a modest 18.3% strikeout rate. His blend of plus control and solid ground-ball rates makes him a candidate for a three-year pact as he heads into his age-30 season. The Mets will have an interesting decision on whether to tag him with a qualifying offer.

Like Walker, Odorizzi signed late in the 2020-21 offseason on a deal that locked in the first two seasons and gave the player a third-year option. Odorizzi’s contract with the Astros was similarly structured to facilitate a third-year buyout while diminishing the AAV for luxury tax purposes, although he’s deciding on a bit more money. The option was initially valued at $6.5MM with a $3.25MM buyout, but the Associated Press provided a breakdown of various escalators. The option value would jump by $2MM apiece if Odorizzi reached 20, 25 and 30 appearances between 2021-22 in which he either started the game or worked four-plus innings of relief. The buyout value would spike by $1MM apiece for hitting each of those thresholds.

Odorizzi has already made 41 such appearances over the past two years, so he’s long since maxed out both thresholds. He’ll therefore be deciding between a $12.5MM option to return to the Braves or taking a $6.25MM buyout and heading to free agency. With only a $6.25MM difference between the option value and the buyout, Odorizzi looks like a borderline opt-out case. He owns a 3.90 ERA across 85 1/3 innings this season, although his 18.3% strikeout rate is a few points below league average. He’ll be 33 by next Opening Day, and he didn’t find as robust interest as most expected he would during his last trip through free agency. He’s a quality strike-thrower and a perfectly fine back-of-the-rotation starter, but it’s now been three years since he’s missed bats at an above-average rate, and he was traded this summer in a one-for-one swap for an underperforming reliever (Will Smith).

Easy Calls To Return

  • Chris Sale, Red Sox LHP (can opt out of final two years and $55MM)

Sale has the right to pass on the final two years of his extension with the Red Sox this winter, but he certainly won’t do so. He’s made just 11 starts over the past three seasons due to various injuries, including a 2020 Tommy John surgery and a trio of fractures (rib, finger and wrist) this year. Sale has still flashed mid-rotation or better upside in the limited time he’s been on the field, but there’s too much uncertainty with his health to land anywhere near $55MM were he to test the market.

  • Eric Hosmer, Red Sox 1B (can opt out of final three years and $39MM)

Hosmer’s opt-in decision is a no-brainer. Since signing a $144MM contract with the Padres heading into 2018, he’s posted a league average .264/.325/.409 slash line. Paired with his lack of defensive versatility and mixed reviews on his glovework (public metrics have never been as fond of Hosmer as his four Gold Gloves would suggest), he’d probably be limited to one-year offers were he a free agent. The Padres will remain on the hook for virtually all of the money, as they agreed to pay down Hosmer’s deal to the league minimum salary to facilitate his trade to the Red Sox.

  • Jorge Soler, Marlins LF (can opt out of final two years and $24MM; deal also contains post-2023 opt-out if Soler opts in this year)

Soler parlayed a big second half and huge batted ball metrics into a three-year deal with Miami last offseason. His massive raw power hasn’t translated into especially strong results since he’s become a Marlin, however. He’s been a below-average hitter, and it’s now been three years since he was a middle-of-the-order caliber player over a full season. Paired with a limited defensive profile that keeps him in the corner outfield or at designated hitter, he’s been right around replacement level this season. He’s not opting out this year, but a big showing in 2023 could allow him to reconsider the possibility next winter.

  • AJ Pollock, White Sox LF ($11MM option, $5MM buyout)

The White Sox acquired Pollock just before the start of the season, sending Craig Kimbrel to the Dodgers in a surprising one-for-one swap. The hope was that they’d addressed a notable hole in the corner outfield, but Pollock’s production has cratered in Chicago. Just a season removed from a .297/.355/.536 showing in L.A., he’s stumbled to a .237/.284/.363 line through 401 plate appearances with the ChiSox. Even with a fairly modest $6MM gap between the option’s present value and the buyout, Pollock is likely to bypass a trip to free agency after a replacement-level platform season.

The present $11MM option value isn’t fixed, as Pollock’s contract contains escalators that could boost it a bit further. Originally set at $10MM, he’d lock in an extra $1MM for hitting each of 400, 450, 500, 550 and 600 plate appearances this season. He’s already surpassed 400 trips, and the 450 mark is well within range with 34 games remaining. Consistent playing time down the stretch would allow him to reach 500 plate appearances as well, although it’s hard to envision him getting to 550. The most likely outcome is that the option price ends up at $12MM, but anywhere between $11-13MM is viable.

Schoop signed a two-year, $15MM extension amidst a productive 2021 season in Detroit. While a defensible enough decision for the Tigers at the time, that hasn’t panned out. The veteran second baseman has a .235 on-base percentage that’s easily the worst in the majors among players with 400+ plate appearances. He’s posted otherworldly defensive marks this season and could well collect a Gold Glove, but the complete lack of production at the dish should make him a lock to exercise his option.

Blackmon exercised a 2022 option last season, and he went on the record at the time as saying he’d trigger the 2023 provision as well. There’s no intrigue as to his decision — he’ll be back in Colorado next year — the only question is how much he’ll make. The ’23 option came with a $10MM base value, but ESPN reported it’d escalate by $500K apiece if Blackmon reached 400, 425, 450, 475, 500, and 525 plate appearances in 2022. It’d jump another $1MM apiece at 550 and 575 trips.

The veteran outfielder enters play Tuesday with 490 plate appearances, so he’s already pushed the value to $12MM. Barring injury, he’s a lock to hit at least the 525 PA mark, and he’s quite likely to get all the way to 575. Colorado has 33 games remaining, and Blackmon is only 85 plate appearances (2.76 per game) from maxing out the plate appearance threshold at $15MM. The deal also contained escalators based on MVP finishes which Blackmon will not hit.

Relievers

  • Nick Martinez, Padres RHP (can opt out of final three years and $19.5MM this offseason, $1.5MM buyout; deal also contains opt-out chances after 2023 and 2024 if Martinez opts in)

Martinez signed a four-year, $25.5MM guarantee with San Diego this past winter. That deal contained opt-out chances after each of the first three seasons for the former NPB hurler, but it seems unlikely Martinez will take his first opportunity to return to the open market. He has a strong 3.02 ERA over 92 1/3 innings during his return season in the big leagues, but he’s worked as a swingman for a San Diego team that has quite a bit of rotation depth. Martinez has excelled as a reliever, pitching to a 1.35 ERA while holding opponents to a .208/.258/.295 line in 40 innings. That’s come with a modest 21.5% strikeout rate, though, and he doesn’t brandish the power arsenal teams tend to prioritize late in games.

Entering his age-32 season, Martinez probably wouldn’t find a better deal that the opt-out laden three years and $18MM (after factoring in the buyout price) he’d be bypassing to return to the open market. The Friars have to be happy with their investment considering his excellence out of the bullpen, but the surprisingly strong deal they gave him in the first place makes it hard to see him doing much better elsewhere even on the heels of a quality first season.

Detroit signed the ever-reliable Chafin late last offseason, and they’ve been rewarded with another excellent year. Through 43 1/3 innings, he’s posted a 2.91 ERA while striking out more than 30% of opponents with an excellent 52.3% ground-ball rate. The market probably undervalued Chafin last winter; it’d be hard to do so again after another very good season. In a vacuum, declining the option and topping $6.5MM in free agency seems likely.

That said, the Tigers decision to not trade Chafin at this summer’s deadline was tied to a belief he could stick around. Evan Petzold of the Detroit Free-Press reported shortly before the deadline that Detroit’s proximity to Chafin’s Ohio home could lead him to return in 2023 if he weren’t moved before August 2. That led to a disconnect in his trade value, with the Tigers confident they still possessed a year and a half of his services while other clubs viewed him as an impending free agent. From a strict financial perspective, opting out is the prudent call. Yet the family considerations Petzold noted would make the decision more complicated if Chafin’s priority isn’t simply to maximize his earnings.

San Diego added Suárez, who’d never previously pitched in the majors, on the heels of an excellent career closing in Japan. He had a nightmare outing on Opening Day where he dished out free passes to all three batters he faced, but he’s been quite effective since that point. Excluding his first appearance, Suárez owns a 2.36 ERA with a strong 29% strikeout rate in 34 1/3 innings. He’s still had spotty control, but he’s averaging north of 97 MPH on his fastball. He’d only need to beat $4MM on the open market, and something around that rate over a multi-year term feels attainable heading into his age-32 season. A rough final couple months could change the calculus, but Suárez seems likely to retest free agency at the moment.

Chi Chi Gonzalez Opts Out Of Deal With Tigers

By | at

Right-hander Chi Chi González has triggered an opt-out clause in his minor league contract with the Tigers, reports Jon Heyman of the New York Post (Twitter link). He returns to the open market.

It was a brief run in Detroit for the 30-year-old, who signed one month ago. He started four of five outings with Triple-A Toledo, working to a 5.48 ERA over 21 1/3 innings. González only struck out 19.4% of opposing hitters during that time, but he induced ground-balls at a huge 58.5% clip. Detroit nevertheless decided against adding him to the big league roster, and he’ll explore his other options.

González has already gotten to the majors with two teams this season. He began this season on a non-roster pact with the Twins and was selected to the majors on two separate occasions. After being designated for assignment in June, he was claimed off waivers by the Brewers. He started two of four games for Milwaukee before being taken off the roster again. That time around, González cleared waivers and elected free agency.

Between the two clubs, he has a 6.87 ERA in 18 1/3 frames. González also posted an ERA north of 6.00 with the Rockies from 2020-21, but he’s capable of serving as either rotation or long relief depth. It seems likely he’ll get another minor league opportunity elsewhere. If he signs before September 1, he’d be eligible for a new team’s postseason roster.

Tigers Place Jonathan Schoop On 10-Day Injured List

By | at

  • The Tigers placed second baseman Jonathan Schoop on the 10-day injured list, retroactive to August 21, with a sprained right ankle. It’s the first IL stint in two years for the veteran infielder, who has played in just under 95% of Detroit’s games since the start of 2021. Schoop posted above-average numbers last year to earn a contract extension in August, but he’s had a dreadful showing offensively this season. Over 447 plate appearances, he’s hitting only .202/.235/.318 with nine home runs. Defensive metrics have been enamored with his glovework at the keystone, but no other qualified hitter is within 19 points of Schoop’s league-worst on-base percentage. He’s likely to exercise a $7.5MM player option this winter to return to the club for 2023.
  • Sticking with the Tigers, manager A.J. Hinch cast doubt on the possibility of seeing catcher Jake Rogers this season (via Cody Stavenhagen of the Athletic). Rogers underwent Tommy John surgery last September, and he’s spent the entire year on the 60-day injured list while rehabbing. It’s almost been a calendar year since that operation. The 27-year-old Rogers hit .182/.264/.378 in 255 plate appearances between 2019-21.

Tigers Release Wily Peralta

By | at

The Tigers announced that right-hander Wily Peralta has cleared waivers and been granted his release. He had been designated for assignment last week.

Peralta, 33, had a very nice season for the Tigers in 2021, registering a 3.07 ERA over 93 2/3 innings. There were reasons to suspect that it wasn’t totally sustainable, however, especially given his 14.4% strikeout rate, which was well below average. A .259 batting average on balls in play probably played a factor as well. As such, despite that strong ERA, Peralta had to settle for re-signing with the Tigers on a minor league deal for 2022.

He eventually had his contract selected in mid-April, guaranteeing himself a $2.5MM base salary. Detroit dealt with numerous injuries to its pitching staff all year long, ensuring that there was always a need for Peralta’s services. Even Peralta himself was not immune, missing almost a month due to a hamstring strain. But when he was present, he was still effective, putting up a 2.58 ERA over 38 1/3 innings and an improved strikeout rate of 19%, though an elevated 14.3% walk rate.

However, with the club out of contention, they plan to use the remainder of the season to evaluate pitchers for long-term purposes, seeing how they fit into the roster for 2023 and beyond. As Eduardo Rodriguez returned from his lengthy absence, the club let Peralta go, with manager A.J. Hinch saying that “We’re giving Wily Peralta a chance to pitch somewhere else while we look at some guys who are more likely to be here.”

There’s around $588K remaining on Peralta’s $2.5MM salary, which the Tigers will now be on the hook for since he cleared waivers. If any team were to sign him now, they would only be responsible for the prorated league minimum, with that amount being subtracted from what the Tigers pay.

Injury Notes: Walker, Thompson, Garcia

By | at

Mets’ starter Taijuan Walker will not make his scheduled start tomorrow, manager Buck Showalter tells Tim Healey of Newsday. The righty has been dealing with a bulging disc in his back, which could push him back to Tuesday. Although it’s good that the injury isn’t significant enough to send him to the injured list, it still creates a short-term problem for the Mets.

Since they also sent Carlos Carrasco to the IL recently and are playing a doubleheader today, they will have to come up with some sort of solution to trudge through to their next off-day, which is on Wednesday. Max Scherzer can go on Monday. Jacob deGrom could start Tuesday but could also get some extra rest if Walker is ready to go. Chris Bassitt pitched last night and isn’t an option for a few days. David Peterson and Trevor Williams are scheduled to start today’s games, but Williams isn’t fully stretch out and was only able to throw four innings in the first game.

Jose Butto is the only starter on the 40-man roster that could be recalled, which seems to be in the cards since Healey relays that Butto is on the taxi squad. It would be a big jump for Butto if he is thrown into tomorrow’s game, since he’s been in Double-A all season and only got promoted to Triple-A on August 8. He has a 4.12 ERA on the year between the two levels.

Other injury tidbits from around the league…

  • The Cubs placed starter Keegan Thompson on the 15-day injured list today, tweets Jordan Bastian of MLB.com. Thompson is dealing with low-back tightness and will have to miss a few turns through the rotation. This will put at least a temporary hold on what has been a nice breakout season for the 27-year-old. Through 25 games this year, 17 starts, he has a 3.97 ERA, 20.5% strikeout rate, 8.3% walk rate and 40% ground ball rate. The Cubs have little reason to push Thompson if he’s not feeling 100%, given that they are well out of contention at this point in the season. They also have little certainty in their rotation going forward, with Marcus Stroman and Kyle Hendricks taking two spots next year, leaving plenty of room for less experienced pitchers like Thompson next year.
  • The Tigers have had nothing but miserable luck on the injury front this year, with just about every starting pitching option spending at least some time on the IL. Rony Garcia has made 16 appearances for the club this year, with eight of those being starts. However, he might not be able to add to that total, with manager A.J. Hinch telling Cody Stavenhagen of The Athletic that Garcia is likely done for the year. He’s been on the IL since late July due to shoulder soreness, the second time this year a shoulder issue landed him on the shelf. It seems it’s lingering long enough that he might not make it back to the hill this year. If that’s indeed the case, he’ll finish the season with a 4.41 ERA over 51 innings.

Big Hype Prospects: Grissom, Walker, Holliday, Lee, Painter

By | at

This week on Big Hype Prospects, we check in with a couple recently-promoted Major Leaguers, peek at a couple more on the cusp, and introduce ourselves to some hot-hitting 2022 draftees.

Five Big Hype Prospects

Vaughn Grissom, 21, 2B/SS, ATL (MLB)
35 PA, 2 HR, 2 SB, .406/.457/.656

Grissom was just playing his way into consensus Top 100 status when the Braves tabbed him for a Major League promotion instead. He had just 98 plate appearances in Double-A after spending much of the season in High-A (344 PA, 11 HR, 20 SB, .312/.404/.487). His numbers have actually improved slightly at each stop. As many have noted (unpleasant noise warning), he’s the second player the Braves have skipped straight past Triple-A. Of course, 35 plate appearances is hardly the basis for Major League success – the true challenge is proving the ability to counter-adjust once the league figures him out. We might not get to that point since Ozzie Albies is approaching a rehab assignment. Grissom will probably hold down the fort until then.

His arrival also has long-term implications. He mostly played shortstop in the minors. So too did Albies back in the day. The club could be using this opportunity to further their postseason bid by using a more dynamic player than Ehire Adrianza while at the same time assessing if a shortstop signing is an urgent need this winter. If they like what they see from Grissom, the Braves might opt to target a lesser free agent like Jose Iglesias or even skip the market altogether.

Jordan Walker, 20, 3B, STL (AA)
430 PA, 15 HR, 17 SB, .310/.393/.522

On Thursday, Walker had his third double-dinger game since July 29. He appears to have accomplished all that he can in Double-A by both improving upon his walk and strikeout rates while continuing to punish the baseball. One of the big impending storylines of free agency is Nolan Arenado’s player option decision. Will he stay or hit the open market? Judging by the ascendancy of Walker, St. Louis might be alright with letting Arenado walk. After all, they can always use Nolan Gorman at third base if Walker isn’t ready in early 2023.

There are still some issues with Walker’s game hidden underneath the beautiful surface level stats. For one, he has a 16.1 percent swinging strike rate. That’s roughly on par with Adolis Garcia, Ryan Mountcastle, Jorge Mateo, and Patrick Wisdom – not exactly the most contact-oriented collection of batters. Moreover, Walker has these whiff issues while running a 45 percent ground ball rate. One of the “tricks” for striking out less is to flatten a swing plane. That adds grounders at the expense of fly balls. Walker has nothing left to give on that front. For what it’s worth, some of the next guys up on the swinging strike rate list are Julio Rodriguez, Teoscar Hernandez, Rafael Devers, and Byron Buxton. Stars can sometimes have whiff problems without dreadful strikeout rates.

Jackson Holliday, 18, SS, BAL (CPX)
6-for-15, 1 HR, 1 SB, 5 BB, 1 K

The number one overall pick of the 2022 draft, Holliday arrived with a bang in the complex league this week. He hit his first professional home run on Friday and has a five-to-one walk-to-strikeout ratio. MLB Pipeline already rates him the 14th-best prospect in the league – an aggressive ranking compared with the recent updates from Baseball America (39) and Keith Law (42). Scouting notes on Holliday remain sparse, mostly focusing on his excellent pre-draft conditioning as well as a need to see him against more advanced competition. With the way he’s playing in his first week, a promotion could come soon.

Brooks Lee, 21, SS, MIN (A+)
30 PA, 1 HR, .333/.400/.444

Another recent first-round draftee, Lee made short work of the complex league. The Twins liked his hit tool so much they assigned him straight to High-A. There, he’s more than held his own albeit with more swing-and-miss than expected. Given the aggressive assignment – nearly every player in High-A has years rather than a few scant weeks of professional experience – Lee’s early success is encouraging. Law believes Lee “is the ne plus ultra” of fast-moving college draftees, meaning we could see him broach the Majors as early as next season. Law also considers a move to third base likely while other sources think Lee can stick at shortstop so long as he’s well-positioned.

The ”fast-mover” middle infield profile typically consists of a near-elite hit tool and nonexistent power. Think Nick Madrigal. Lee’s power is more aptly described as nascent. He’s expect to grow into 10 to 20 home runs annually to go with a disciplined, high-average approach.

Andrew Painter, 19, SP, PHI (A+)
(A+) 36.2 IP, 12.03 K/9, 1.72 BB/9, 0.98 ERA

Last week, we covered Ricky Tiedemann in this spot. Many of the same superlatives apply to Painter. He’s the same age as Tiedemann and rapidly ascending towards Top 10 prospect status. He’s one of the best pitchers left in the minors. At present, Painter has a fastball-slider combo that evokes Spencer Strider. Painter lives upstairs with 98-mph heat then drops sharp sliders into the strike zone. Scouting reports indicate his ability to locate the slider outside of the zone is still a work in progress as are the development of a curve and changeup. Given Strider’s success with the same toolkit, Painter might just find his way to the Majors next season as a two-pitch 20-year-old.

Five More

Josh Jung, TEX (24): Last week, we noted Jung’s successful return to Triple-A. Since then, he’s gone 10-for-20 with four home runs, three doubles, two walks, and a strikeout. A promotion should come any day now.

Sal Frelick, MIL (22): Speaking of hot bats, Frelick is hitting .440/.525/.540 through his first 60 Triple-A plate appearances with more walks than strikeouts. The Brewers have fallen three games behind the Cardinals in the NL Central and two games back of the Phillies in the Wild Card race. Milwaukee could consider taking a page from the Braves by promoting Frelick before he’s ticked all the usual developmental boxes. Center field and leadoff hitter are their biggest areas of need. Frelick profiles as Steven Kwan-like.

Brayan Bello, BOS (23): Bello is slated to make a rehab start at Triple-A on Friday. If all goes well, he could return to the Majors in short order. While it’s trendy to count the Red Sox out of the playoff hunt, they’re only five games behind the Rays and Jays. They’re six back of the Mariners. A recovery is certainly possible. Bello, with his domineering stuff and over-60 percent ground ball rate, could be an important piece if Boston is to salvage their season.

Kerry Carpenter, DET (24): A late-bloomer who only started generating hype this season, Carpenter thrashed the upper-minors for 30 home runs in 400 plate appearances. He’s since tacked on two dingers in 25 Major League plate appearances. As expected, he’s shown signs of below average plate discipline and a modest swinging-strike issue in his small sample of big league experience. Overall, his debut has been a rousing success to date so the Tigers have every reason to continue trotting him out on a daily basis.

Marcelo Mayer, BOS, (19): In recent years, we’ve been spoiled with precocious play from young, top prospects. Of all the Top 10 prospect candidates, we’ve had the least to say about Mayer in this column. The long and short of it is he’s having a typical season for a prospect of his age and repute. He hasn’t done anything jaw-dropping while at the same time assuring onlookers of his eventual role as a Major League shortstop of some quality. Personally (remember, I’m not a scout), I see similarities to J.P. Crawford with eventual power outcomes being a tad more accessible/plausible. Since a recent promotion to High-A, he’s hitting .243/.333/.405 in 42 plate appearances.

Tigers Reinstate Eduardo Rodriguez, Designate Wily Peralta

By | at

The Tigers have reinstated left-hander Eduardo Rodriguez from the restricted list, tweets Daniel Álvarez-Montes of El Extra Base. Right-hander Wily Peralta was designated for assignment in a corresponding move.

Rodriguez, 29, was signed in the offseason to a five-year, $77MM contract, with the Tigers hoping he could be a veteran anchor of their young rotation. Detroit had debuted many promising young starters in previous seasons, including Casey Mize, Matt Manning, Tarik Skubal and others. It was hoped that those youngers, combined with the addition of Rodriguez, could give the club a strong rotation and help them emerge from their years-long rebuild.

Unfortunately, Murphy’s law has been applied to the Tigers in the strictest possible terms this season, with their rotation being heavily targeted. Mize made just two starts before landing on the injured list, eventually undergoing Tommy John surgery, keeping him out of action for this year and likely most of next year as well. Manning has since returned but missed almost four months due to shoulder issues, having made just five starts so far this year. Skubal stayed healthy for a while, making 21 starts, but recently underwent a flexor tendon surgery that will finish his 2022 and likely keep him out of action for part of 2023 as well.

As for Rodriguez, he landed on the injured list in May due to a ribcage sprain. He started a rehab assignment in early June but was then transferred to the restricted list due to a personal matter which was later reported to be a marital issue. He returned to begin another rehab assignment in early August, working back up to a starter’s workload before today’s return. In the end, Rodriguez spent just over two months on the restricted list, during which time he didn’t take up a spot on the 40-man roster or earn any salary. Prior to that extended absence, he made eight starts for Detroit, registering a 4.38 ERA in 39 innings.

With the club’s rotation being so snakebit all year, they have had to churn through various backup plans over the course of the season. One of those was Peralta, 33, who was signed to a minor league deal in the offseason. He was selected to the roster in mid-April and appeared in 28 games. In 38 1/3 innings on the year, he has a 2.58 ERA, not missing bats entirely but at least missing the most important part. His 19% strikeout rate is below league average but he’s in the 89th percentile in terms of barrel percentage. Perhaps due to keeping hitters off-balance, his 5.6% HR/FB rate is less than half his career rate, helping to keep his ERA down.

Despite those solid results, Peralta will head to the waiver wire in the coming days, as the trade deadline is now behind us. Manger A.J. Hinch spoke to reporters about today’s moves, including Chris McCosky of the Detroit News, explaining that they want to use the remainder of the season to evaluate younger pitchers. “We’re giving Wily Peralta a chance to pitch somewhere else while we look at some guys who are more likely to be here,” Hinch said.

Hinch also explained that Daniel Norris and Garrett Hill will be moved to the bullpen, as the club has multiple off-days coming up and can survive with a four-man rotation for a few weeks. In Hill’s case, the move is about limiting his innings down the stretch in order to avoid overworking him. The club’s rotation for the time being will consist of Rodriguez, Manning, Tyler Alexander and Drew Hutchison.

Injury Notes: Mahle, Meadows, Walker, Johnson

By and | at

The Twins are surely breathing a sigh of relief, announcing to reporters Thursday that an MRI revealed right-hander Tyler Mahle’s shoulder to be structurally sound. Mahle, acquired from the Reds in exchange for three prospects earlier this month, exited yesterday’s start after just 2 1/3 innings due to shoulder fatigue. That was of particular concern, given that he also missed time in July with what was termed by the Reds as a “minor'” shoulder strain. For the time being, there are no plans to place Mahle on the 15-day injured list, though it’s not yet clear whether his next start will be pushed back at all.

Mahle’s Wednesday start saw his fastball clocking in around four miles per hour shy of his typical 93.4 mph average, so there’s still some obvious concern, but the absence of a tear or any structural issues is about the best news for which the Twins could have hoped. In 14 1/3 innings as a Twin, Mahle has pitched to a 2.51 ERA with a 23.1% strikeout rate and a 7.7% walk rate. Mahle, Sonny Gray, Joe Ryan, Chris Archer and Dylan Bundy are in line to make the majority of the Twins’ starts down the stretch, though they’re expecting right-hander Bailey Ober back in September and just this week promoted prospect Simeon Woods Richardson from Double-A to Triple-A.

Some more injury scenarios of note from around the league…

  • As if things couldn’t get any worse for the Tigers, manager A.J. Hinch announced this week that outfielder Austin Meadows has once again been pulled from a rehab assignment (link via Chris McCosky of the Detroit News). Meadows first hit the injured list back in mid-May due to vertigo-like symptoms and returned a bit less than a month later. That return lasted only eight games, however, before he was placed on the Covid-related injured list. Just as Meadows was getting ready to head out on a rehab assignment, he was transferred to the 10-day injured list owing to the bizarre diagnosis of an Achilles strain in both legs. This now marks the second time that Meadows has had a rehab assignment for this injury halted. Hinch’s only update was that Meadows was headed to Detroit for reevaluation and that the Tigers still have hope he can return in 2022. It’s been a nightmare of a season for Meadows, who has been limited to just 147 plate appearances and seen his power disappear: .250/.347/.328.
  • Mets righty Taijuan Walker left his most recent start due to back spasms, with an MRI revealing a slight disc bulge in his lower back, reports Anthony DiComo of MLB.com. However, it’s possible he could make his next scheduled start on Sunday. Walker tells DiComo that he is “shocked” to be feeling so good so soon after experiencing “the worst pain I ever felt.” Although he’s feeling better, he still won’t take the mound on Sunday unless he’s feeling 100 percent, per DiComo. If he is indeed recovered, it would be a tremendous gift for the Mets, given the current pressures on their rotation. With Carlos Carrasco recently landing on the IL and the Mets having a doubleheader on Saturday, having to make it through Sunday without Walker would certainly be a challenge. How his back responds over the next few days will determine if the club can avoid that tricky scenario.
  • Padres reliever Pierce Johnson is heading out on a rehab assignment, tweets Kevin Acee of the San Diego Union-Tribune. Johnson had an excellent season for San Diego a year ago, throwing 58 2/3 innings with a 3.22 ERA and 31.6% strikeout rate. The Friars held a $3MM club option over Johnson’s services for this year, which they exercised based on that strong showing last season. Unfortunately, Johnson landed on the IL in April due to elbow tendinitis. He’s yet to return, meaning he’s only been able to get into six games this year. After a layoff of about four months, it seems he’s healthy enough to get back into game shape. Once he’s ready to return to the big league club, he should give the bullpen a boost for the final few weeks of the season.

Tarik Skubal Undergoes Flexor Tendon Surgery

By | at

Tigers left-hander Tarik Skubal underwent surgery to repair the flexor tendon in his left forearm this week, manager A.J. Hinch announced to reporters (Twitter link via Evan Petzold of the Detroit Free Press). Skubal was already known to be out for the remainder of the 2022 season after being shifted to the 60-day injured list last week, but a surgery of this nature is significant and calls into question his readiness for the 2023 campaign. The Tigers have not provided a timetable for his recovery.

It’s a rather alarming escalation of events regarding Skubal, who just three weeks ago was at least a long-shot trade candidate in the midst of a breakout season. He exited an Aug. 1 start against the Twins after five excellent innings — three hits, no runs, no walks, four strikeouts — due to what the team termed as arm fatigue. At the time of his removal, Skubal downplayed the injury and voiced confidence that he could make his next start. As such, the subsequent trip to the 15-day injured list was viewed as something of a precautionary measure at the time.

Concern began to mount, however, when the Tigers abruptly shifted him to the 60-day injured list on Aug. 12. Hinch told reporters that day that Skubal was meeting with renowned surgeon Dr. Neal ElAttrache to get an additional opinion on his elbow and forearm. The Tigers definitively shut him down for the season at that point.

Flexor tendon surgery doesn’t necessarily come with as lengthy of a recovery period as the typical 12 to 14 months for Tommy John surgery, but it’s hardly a short-term outlook in most cases. Every procedure and recovery process is different, but it’s worth noting that a pair of high-profile lefties — Danny Duffy and Skubal’s former teammate, Matthew Boyd — underwent similar procedures last year and have not yet made it back to the mound. Boyd (September surgery) and Duffy (October) were both targeting June returns but have since encountered setbacks that have impeded their progress.

Again, there are plenty of instances of pitchers returning from this injury more promptly, and the Tigers haven’t provided specifics on Skubal’s surgery. There’s no sense in attempting to speculate on a specific return date with incomplete information. That said, we’re about six months out from the start of 2023 Spring Training already, so simply looking to other flexor surgeries in recent years, it’s fair to wonder whether Skubal’s availability early in 2023 might be impacted.

It’s another blow to what’s been an astonishingly snakebitten Tigers pitching staff in 2022. For the past several years, the tantalizing trio of Skubal, Casey Mize and Matt Manning — all of them former top-100 prospects — was heralded as the foundation of Detroit’s pitching staff for years to come. Instead, that trio has been beset by injuries, two of which have now resulted in major surgeries. Skubal will face a months-long recovery from his flexor procedure. Mize underwent Tommy John surgery earlier this year. Manning hasn’t gone under the knife but has dealt with a notable shoulder injury this year and a forearm strain of his own back in 2020. At the very least, Manning is healthy at the moment; he came off the injured list earlier this month and has made three solid appearances — though those are just his third, fourth and fifth starts of the season.

Detroit’s struggles extend well beyond injuries to that promising group of arms, however. Top outfield prospect Riley Greene missed the first two-plus months of the season with a broken foot and has been overmatched by MLB pitching since returning (.228/.287/.330 in 244 plate appearances). Both Greene and first baseman Spencer Torkelson were ranked among the game’s top five overall prospects heading into the season, but Torkelson endured similar struggles (.197/.282/.295) before being optioned to Triple-A earlier in the summer.

The Tigers have also had notable injuries to expected contributors (Austin Meadows, Michael Pineda), seen established 2021 contributors regress (Jeimer Candelario, Akil Baddoo) and received nowhere near the help they expected from their top two free-agent signings. Javier Baez is hitting just .227/.269/.378 on the year, while lefty Eduardo Rodriguez has pitched just 39 innings due to injury and to time spent away from the team while dealing with a reported marital issue. Rodriguez is expected to return this weekend (Twitter link via Evan Woodbery of MLive.com), but the team’s season has clearly already gone off the rails.

Any of these woes, in isolation, would perhaps be manageable for a team to overcome. Taken in totality, however, there’s no reasonable way to expect a team to withstand that type of strain on the roster. The dam finally burst last week when the Tigers fired general manager Al Avila.

The Tigers will have a new general manager within the coming months, but it’s not yet clear just how said executive and how owner Chris Ilitch envision fixing the mess that has been the 2022 season. That much was true even before the Tigers learned that their top young starter required surgery to repair a flexor tendon. Skubal made 21 starts this season and pitched to a solid 3.52 ERA with an above-average 24.5% strikeout rate, a strong 6.7% walk rate and a quality 45.7% grounder rate.

Prior to his injury, Skubal’s development was one of the very few bright spots in an otherwise calamitous Tigers season, but he’ll now add to the daunting sense of uncertainty that permeates the roster. The Tigers control Skubal and Mize through the 2026 season. Manning is controllable through 2027. Torkelson and Greene can be controlled through at least 2028.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

hide arrows scroll to top